Other languages Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Market Closed - NSE India S.E. Other stock markets 12:43:49 02/05/2024 BST			5-day change	1st Jan Change
1,519 ^INR	+1.13%		+2.31%	+20.61%

04-23	Indian Equities End Higher for Third Straight Day, Lifted by Real Estate, IT Stocks	MT
04-19	Sun Pharmaceutical Industries Limited Company Receives an Order Passed by Asst. Commissioner (S.T) Madurantagam Assessment Circle	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Indian Equities End Higher for Third Straight Day, Lifted by Real Estate, IT Stocks	04-23
Los mercados de India cierran a la baja en medio de sentimientos tibios de los inversores -- Market Talk	04-12
Indian Equities Close Lower on Friday As Hopes for US Rate Cute in June Fade	04-12
Sun Pharmaceutical's Dadra, India Unit Gets 'Official Action Indicated' Status from US FDA	04-12
INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes	04-12
Bausch wins US appeal to block Alvogen generic of diarrhea drug	04-11
Sun Pharmaceutical Industries Appoints Chief Information Officer	04-04
Sun Pharmaceutical Industries Limited Announces Executive Changes	04-03
Sun Pharmaceutical Industries Limited Announces Retirement of Sailesh Trambaklal Desai as Director	03-29
Bourse Zurich: le SMI finit sous la barre des 11'600 points	03-19
Bourse Zurich: le SMI à la peine, Partners Group plombe l'ambiance	03-19
Bourse Zurich: ouverture en petite forme attendue	03-19
Cosmo: feu vert pour la commercialisation du Winlevi aux antipodes	03-19
Cosmo erhält Zulassung für Winlevi in Australien	03-19
Cosmo Pharmaceuticals Partner Gets Regulatory Approval for Acne Treatment in Australia	03-19
Sun Pharmaceutical's Acne Drug Gets Approval in Australia	03-19
Sun Pharmaceutical Industries Limited Announces Approval of Winlevi in Australia	03-19
Upbeat Global Markets, Strong GDP Send Indian Equities to Record Closing High on Friday	03-01
Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	03-01
EXCLUSIVA-Eli Lilly podría lanzar un fármaco contra la obesidad en India el próximo año: presidente ejecutivo	02-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Other languages

Filters